When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...

When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

Adolescents with cancer and their parents said parents should have access to non-sensitive information in patient portals.

HHS Secretary Robert F. Kennedy Jr. abruptly postponed a meeting of the USPSTF, raising concerns that he will be reshaping the task force.

The FDA has accepted the supplemental new drug application for decitabine/cedazuridine plus venetoclax to treat adults with AML.

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term adverse effects such as second malignancies and infertility, ...

The Trump administration's recent travel and visa restrictions are preventing medical residents from starting their jobs in the US.

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

The FDA has published more than 200 complete response letters, sent as replies for applications submitted from 2020 to 2024.

The addition of metformin “was generally well tolerated but did not result in the targeted benefit of a 20% reduction in risk of death in an unselected population,” the researchers wrote.

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.